Sit Investment Associates Inc. cut its holdings in shares of Aetna Inc (NYSE:AET) by 41.2% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 69,557 shares of the company’s stock after selling 48,800 shares during the period. Sit Investment Associates Inc.’s holdings in Aetna were worth $12,547,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other hedge funds and other institutional investors have also bought and sold shares of AET. FMR LLC raised its position in shares of Aetna by 73.8% in the second quarter. FMR LLC now owns 13,736,800 shares of the company’s stock worth $2,085,659,000 after acquiring an additional 5,833,567 shares during the period. Janus Henderson Group PLC raised its position in shares of Aetna by 9,446.2% in the second quarter. Janus Henderson Group PLC now owns 4,328,900 shares of the company’s stock worth $657,255,000 after acquiring an additional 4,283,553 shares during the period. Capital World Investors raised its position in shares of Aetna by 8.9% in the second quarter. Capital World Investors now owns 20,769,004 shares of the company’s stock worth $3,153,358,000 after acquiring an additional 1,688,767 shares during the period. Orbimed Advisors LLC raised its position in shares of Aetna by 57.3% in the third quarter. Orbimed Advisors LLC now owns 1,396,500 shares of the company’s stock worth $222,057,000 after acquiring an additional 508,600 shares during the period. Finally, Samlyn Capital LLC acquired a new position in shares of Aetna in the second quarter worth about $77,170,000. Institutional investors own 87.80% of the company’s stock.
A number of research analysts have weighed in on AET shares. Zacks Investment Research upgraded shares of Aetna from a “hold” rating to a “buy” rating and set a $174.00 price objective for the company in a research report on Thursday, October 12th. ValuEngine raised shares of Aetna from a “hold” rating to a “buy” rating in a research note on Sunday, December 31st. Piper Jaffray Companies raised shares of Aetna from a “neutral” rating to an “overweight” rating and set a $136.00 target price for the company in a research note on Wednesday, January 3rd. Argus cut shares of Aetna from a “buy” rating to a “hold” rating and set a $185.00 target price for the company. in a research note on Wednesday, December 6th. Finally, Morgan Stanley cut shares of Aetna from an “overweight” rating to an “equal weight” rating and set a $179.00 target price for the company. in a research note on Wednesday, December 20th. Twelve analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company. Aetna currently has a consensus rating of “Buy” and an average target price of $172.64.
Aetna Inc (AET) opened at $183.48 on Thursday. The company has a quick ratio of 0.53, a current ratio of 0.53 and a debt-to-equity ratio of 0.52. Aetna Inc has a fifty-two week low of $116.04 and a fifty-two week high of $192.37. The company has a market cap of $59,830.00, a P/E ratio of 33.91, a PEG ratio of 1.64 and a beta of 0.61.
Aetna (NYSE:AET) last issued its quarterly earnings data on Tuesday, October 31st. The company reported $2.45 EPS for the quarter, topping the consensus estimate of $2.06 by $0.39. Aetna had a net margin of 2.93% and a return on equity of 21.84%. The firm had revenue of $14.99 billion for the quarter, compared to analyst estimates of $15.12 billion. During the same period in the prior year, the business posted $2.07 EPS. The business’s revenue for the quarter was down 5.0% compared to the same quarter last year. research analysts anticipate that Aetna Inc will post 9.78 earnings per share for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 26th. Stockholders of record on Thursday, January 11th will be issued a $0.50 dividend. The ex-dividend date is Wednesday, January 10th. This represents a $2.00 annualized dividend and a dividend yield of 1.09%. Aetna’s dividend payout ratio is currently 36.97%.
COPYRIGHT VIOLATION NOTICE: “Sit Investment Associates Inc. Decreases Position in Aetna Inc (AET)” was reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this piece of content on another website, it was copied illegally and reposted in violation of U.S. & international copyright and trademark legislation. The original version of this piece of content can be accessed at https://www.dispatchtribunal.com/2018/01/11/sit-investment-associates-inc-decreases-position-in-aetna-inc-aet.html.
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.
Receive News & Ratings for Aetna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna and related companies with MarketBeat.com's FREE daily email newsletter.